1van de Wetering J,Westendorp RG,van der Hoeven JG,et al.Heparin use in continuous renal replacement procedures:the steuggle between filter coagulation and patient hemorrhage.J Am Soc Nephrol,1996,7:145-150.
2McMahon LP,Chester K,Walker RG.Effect of different dialysis membranes on serum concentrations of epoetin alfa,darbepoetin alfa,enoxaparin,and iron sucrose during dialysis.Am J Kidney Dis,2004,44:509-516.
3Lim W,Cook DJ,Crowther MA.Safety and efficacy of low molecular weight haparins for hemodialysis in patients with end-stage renal failure:a meta-analysis of randomized trials.J Am Soc Nephrol,2004,15:3192-3206.
4Rophy,omers,aum,et al.ulti-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy.ephrol oal ransplant,2005,20:1416-1421.
5Hetzel GR,Schmitz M,Wissing H,et al.Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemfiltration:a prospective randomized multicentre trial.Nephrol Dial Transplant,2011,26:232-239.
